Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
25°
Mostly Cloudy
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Archives
Best of 2024
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
AngioDynamics, Inc. - Common Stock
(NQ:
ANGO
)
9.820
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Apr 3, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about AngioDynamics, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
Next >
Earnings Scheduled For April 7, 2022
April 07, 2022
Companies Reporting Before The Bell • Cazoo Gr (NYSE:CZOO) is likely to report earnings for its fourth quarter.
Via
Benzinga
AngioDynamics's Earnings: A Preview
April 06, 2022
AngioDynamics (NASDAQ:ANGO) is set to give its latest quarterly earnings report on Thursday, 2022-04-07. Here's what investors need to know before the announcement. Analysts estimate that AngioDynamics...
Via
Benzinga
AngioDynamics's Earnings Outlook
April 06, 2022
AngioDynamics (NASDAQ:ANGO) is set to give its latest quarterly earnings report on Thursday, 2022-04-07. Here's what investors need to know before the announcement. Analysts estimate that AngioDynamics...
Via
Benzinga
A Preview Of AngioDynamics's Earnings
April 06, 2022
AngioDynamics (NASDAQ:ANGO) is set to give its latest quarterly earnings report on Thursday, 2022-04-07. Here's what investors need to know before the announcement. Analysts estimate that AngioDynamics...
Via
Benzinga
AngioDynamics to Present at the Needham Virtual Healthcare Conference
April 04, 2022
From
AngioDynamics, Inc.
Via
Business Wire
The Week Ahead In Biotech (April 3-April 9): BioXcel FDA Decision, Neurology Conference Presentations Take The Spotlight
April 03, 2022
Biopharma stocks outperformed the broader market in the week ending April 2, thereby recouping the losses from the previous week. Clinical readouts and FDA decisions were among the chief catalysts that...
Via
Benzinga
AngioDynamics to Report Fiscal 2022 Third Quarter Financial Results on April 7, 2022
March 14, 2022
From
AngioDynamics, Inc.
Via
Business Wire
AngioDynamics to Present at the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
February 08, 2022
From
AngioDynamics, Inc.
Via
Business Wire
4 Stocks Insiders Are Buying
January 13, 2022
When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stock as a bargain. Either way, t...
Via
Benzinga
AngioDynamics Earnings Perspective: Return On Capital Employed
January 07, 2022
According to Benzinga Pro data, during Q1, AngioDynamics (NASDAQ:ANGO) posted sales of $76.97 million. Earnings were up 64.19%, but AngioDynamics still reported an overall loss of...
Via
Benzinga
AngioDynamics Reports Fiscal 2022 Second Quarter Financial Results; Reaffirms Revenue Guidance; Revises Gross Margin and Adjusted EPS Guidance
January 06, 2022
From
AngioDynamics, Inc.
Via
Business Wire
Earnings Scheduled For January 6, 2022
January 06, 2022
Companies Reporting Before The Bell • Northern Technologies (NASDAQ:NTIC) is estimated to report quarterly earnings at $0.18 per share on revenue of $16.90 million....
Via
Benzinga
AngioDynamics to Present at the Needham Virtual Growth Conference
January 03, 2022
From
AngioDynamics, Inc.
Via
Business Wire
The Week Ahead In Biotech (Jan. 2-Jan. 8): Stray Clinical Readouts In Focus In Slow News Week
January 02, 2022
Biotech stocks came under selling pressure in the final week of 2021, although they carved out modest gains for the year. Here are the key catalysts that can sway biotech stocks in the unfolding week.
Via
Talk Markets
AngioDynamics to Report Fiscal 2022 Second Quarter Financial Results on January 6, 2022
December 15, 2021
From
AngioDynamics, Inc.
Via
Business Wire
Is This Under-the-Radar Medical Devices Stock a Buy?
November 03, 2021
The medical devices company beat analyst expectations in the first quarter of its new fiscal year. Could it be a buy?
Via
The Motley Fool
51 Biggest Movers From Friday
October 18, 2021
Gainers LM Funding America, Inc. (NASDAQ: LMFA) shares jumped 38.1% to close at $4.75 on Friday after declining around 15% on Thursday. The company recently announced it...
Via
Benzinga
10 Biggest Price Target Changes For Friday
October 15, 2021
Cowen & Co. lowered the price target on Domino's Pizza, Inc. (NYSE:
Via
Benzinga
Mid-Afternoon Market Update: Gold Rises 2%; Bed Bath & Beyond Shares Slide
September 30, 2021
Toward the end of trading Thursday, the Dow traded down 0.74% to 34,136.80 while the NASDAQ rose 0.36% to 14,565.16. The S&P also fell, dropping 0.25% to 4,348.69. The U.S....
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Benzinga's Top Ratings Upgrades, Downgrades For October 15, 2021
October 15, 2021
Upgrades B of A Securities upgraded the previous rating for WEC Energy Group Inc (NYSE:
Via
Benzinga
Investors Cheer AngioDynamics' Q1 Beat, Raised FY22 Sales Outlook
September 30, 2021
AngioDynamics Inc (NASDAQ: ANGO) reported a Q1 FY22 adjusted EPS loss of $(0.02), ahead of the consensus of $(0.04). Q1 sales increased 9.6% Y/Y to $77...
Via
Benzinga
51 Biggest Movers From Yesterday
October 01, 2021
Gainers Superior Drilling Products, Inc. (NYSE: SDPI) shares rose 60.6% to close at $1.75 on Thursday after jumping over 23% on Wednesday. The company, last month, reported Q2...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
September 30, 2021
Gainers Progenity (NASDAQ:PROG) stock increased by 21.06% to $1.31 during Thursday's regular session. The current volume of 70.4 million shares is 943.37% of Progenity...
Via
Benzinga
Mid-Day Market Update: Dow Drops Over 300 Points; Virgin Galactic Shares Jump
September 30, 2021
Midway through trading Thursday, the Dow traded down 0.97% to 34,056.76 while the NASDAQ fell 0.09% to 14,499.45. The S&P also fell, dropping 0.58% to 4,334.04. The U.S. has...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
36 Stocks Moving In Thursday's Mid-Day Session
September 30, 2021
Gainers Paltalk, Inc. (NASDAQ: PALT) shares jumped 55% to $13.00. Paltalk engaged ClearThink to lead expanded investor relations program. Farmmi, Inc. (NASDAQ: FAMI) jumped 45.5...
Via
Benzinga
Angiodynamics Inc (ANGO) Q1 2022 Earnings Call Transcript
September 30, 2021
ANGO earnings call for the period ending August 31, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Mid-Morning Market Update: Markets Mixed; CarMax Profit Misses Views
September 30, 2021
Following the market opening Thursday, the Dow traded down 0.11% to 34,352.56 while the NASDAQ climbed 0.44% to 14,576.37. The S&P also rose, gaining 0.15% to 4,365.81. The U....
Via
Benzinga
Topics
Stocks
Exposures
US Equities
The Daily Biotech Pulse: Merck Confirms Acceleron Purchase, Regeneron Touts COVID-19 Antibody Cocktail Data, Takeda In-Licenses Huntington's Disease Drug
September 30, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 29) Acceleron Pharma Inc. (...
Via
Benzinga
Exposures
COVID-19
AngioDynamics Reports Fiscal 2022 First Quarter Financial Results; Updates Guidance
September 30, 2021
From
AngioDynamics, Inc.
Via
Business Wire
Earnings Scheduled For September 30, 2021
September 30, 2021
Companies Reporting Before The Bell • Antelope Enterprise Hldgs (NASDAQ:AEHL) is likely to report earnings for its first quarter. • Paychex (NASDAQ:PAYX) is...
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.